Cargando…
Posterior Reversible Encephalopathy Syndrome Secondary to R-CHOP Chemotherapy Regimen
Chemotherapy-induced posterior reversible encephalopathy (PRES) syndrome is a rare event. Its recurrence after reusing the incriminated molecules remains unpredictable. We report the case of a 58-year-old female patient being followed for a diffuse large B-cell lymphoma treated with rituximab, cyclo...
Autores principales: | Jennane, Selim, Mahtat, El Mehdi, Ababou, Mounir, El Maaroufi, Hicham, Doghmi, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191265/ https://www.ncbi.nlm.nih.gov/pubmed/35719806 http://dx.doi.org/10.7759/cureus.24988 |
Ejemplares similares
-
Acute Laryngeal Dyspnea as the First Presentation of Mantle Cell Lymphoma: A Case Report and Review of the Literature
por: Ababou, Mounir, et al.
Publicado: (2020) -
PB2362: THE EFFECT OF BODY MASS INDEX (BMI) ON THE PROGNOSIS OF DLBCL PATIENTS TREATED WITH R-CHOP: A REAL WORLD MOROCCAN EXPERIENCE
por: el Filali, Imane Ait, et al.
Publicado: (2023) -
Bleomycin-Induced Lung Toxicity in Hodgkin's Lymphoma: Risk Factors in the Positron Emission Tomography Era
por: Jennane, Selim, et al.
Publicado: (2022) -
Prise en charge des syndromes myélodysplasiques au Maroc à propos d´une étude mono-centrique
por: Maaroufi, Hicham El, et al.
Publicado: (2020) -
PB2693: ANEMIA IN HEMATOLOGIC MALIGNANCIES: NOT ONLY A SYMPTOM.
por: Hari, Oumayma, et al.
Publicado: (2023)